Browse > Article

Recent Advances in Anti-inflammatory Synthetic Flavonoids as Potential Drugs  

Kim, Hyun-Pyo (College of Pharmacy, Kangwon National University)
Park, Hae-Il (College of Pharmacy, Kangwon National University)
Publication Information
Natural Product Sciences / v.16, no.2, 2010 , pp. 59-67 More about this Journal
Abstract
Flavonoids are well-known anti-inflammatory agents that exert their effects via a variety of mechanisms including antioxidative action, inhibition of eicosanoid metabolizing enzymes and regulation of theexpression of proinflammatory molecules. In this review, synthetic approaches to obtain more useful flavonoid derivatives are summarized. Human clinical trials of flavonoid therapy are discussed. Through continual investigation to identify more potent and comparable flavonoids, new anti-inflammatory flavonoid therapy will be successfully launched, especially for the treatment of chronic inflammatory disorders.
Keywords
Synthetic flavonoid; Anti-inflammation; Clinical trial;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Gunnarsson, G.T., Riaz, M., Adams, J., and Desai, U.R., Synthesis of persulfated flavonoids using 2,2,2-trichloroethyl protecting group and their factor Xa inhibition potential. Bioorg. Med. Chem., 13, 1783- 1789 (2005).   DOI   ScienceOn
2 Dao, T.T., Chi, Y.S., Kim, J., Kim, H.P., Kim, S., and Park, H., Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives. Bioorg. Med. Chem. Lett., 14, 1165-1167 (2004).   DOI   ScienceOn
3 de Pascual-Teresa, S., Johnston, K.L., DuPont, M.S., O'Leary, K.A., Needs, P.W., Morgan, L.M., Clifford, M.N., Bao, Y., and Williamson, G., Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J. Nutr., 134, 552-557 (2004).   DOI
4 Edwards, R.L., Lyon, T., Litwin, S.E., Rabousky, A., Symons, J.D., and Jalili, T., Quercetin reduces blood pressure in hypertensive subjects. J. Nutr., 137, 2405-2411 (2007).   DOI
5 Dao, T.T., Oh, J.W., Chi, Y.S., Kim, H.P., Sin, K.-S., and Park, H., Synthesis and PGE2 inhibitory activity of vinylated and allylated chrysin analogues. Arch. Pharm. Res., 26, 581-584 (2003b).   과학기술학회마을   DOI   ScienceOn
6 Conquer, J.A., Maiani, G., Azzini, E., Raguzzini, A., and Holub, B.J., Supplementation with quercetin markedly increase plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr., 128, 593-597 (1998).   DOI
7 Beck, G., Bergmann, K., Kebeler, K., and Wess, G., Synthesis of a new flavonoid-antioxidant. Tetrahedron Lett., 31, 7293-7296 (1990).   DOI   ScienceOn
8 Boots, A.W., Wilms, L.C., Swennen, E.L.R., Kleinjans, J.C.S., Bast, A., and Haenen, G.R.M.M., In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutr., 24, 703-710 (2008).   DOI   ScienceOn
9 Cho, H., Yun, C.-W., Park, W.-K., Kong, J.-Y., Kim, K.S., Park, Y., Lee, S., and Kim, B.-K., Modulation of the activity of proinflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharm. Res., 49, 37-43 (2004).   DOI   ScienceOn
10 Chung, M.-I., Han, F.-W., Lin, H.-C., Liou, S.-S., Huang, P.-L., Ko, H.-H., Chang, Y.-L., Kang, J.-J., Teng, C.-M., and Lin, C.-N., Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolamines. J. Pharm. Pharmacol., 53, 1601-1609 (2001).   DOI   ScienceOn
11 Loke, W.M., Hodgson, J.M., Proudfoot, J.M., McKinly, A.J., Puddey, I.B., and Croft, K.D., Pure dietary flavonoids quercetin and (-)- epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr., 88, 1018-1025 (2008).   DOI
12 Chen, X., Cui, L., Duan, X., Ma, B., and Zhong, D., Pharmacokinetics and metabolism of two flavonoid scutellarin in humans after a single oral administration. Drug Metab. Dispos., 34, 1345-1352 (2006).   DOI   ScienceOn
13 Yarishkin, O.V., Ryu, H.W., Park, J.-Y., Yang, M.S., Hong, S.-G., and Park, K.H., Sulfonate chalcone as new class voltage-dependent $K^{+}$ channel blocker. Bioorg. Med. Chem. Lett., 18, 137-140 (2008).   DOI   ScienceOn
14 Viola, H., Marder, M., Wasowski, C., Giorgi, O., Paladini, A.C., and Medina, J.H., 6,3'-Dibromoflavone and 6-nitro-3'-bromoflavone: New additions to the 6,3'-disubstituted flavone family of high-affinity ligands of the brain benzodiazepine binding site with agonistic properties. Biochem. Biophys. Res. Comm., 273, 694-698 (2000).   DOI   ScienceOn
15 Wu, E.S.C., Cole, T.E., Davidson, T.A., Blosser, J.C., Borrelli, A.R., Kingsolving, C.R., and Parker, R.B., Flavones. I. Synthesis and antihypertensive activity of 3-phenylflavone-oxopropanolamines without $\beta$-adrenergic receptor antagonism. J. Med. Chem., 30, 788-792 (1987).   DOI
16 Wu, E.S.C., Loch, J.T., Toder, B.H., Borrelli, A.R., Gawlak, D., Radov, L.A., and Gensmantel, N.P., Flavones. 3. Synthesis, biological activities, and conformational analysis of isoflavone derivatives and related compounds. J. Med. Chem., 35, 3519-3525 (1992).   DOI
17 Yahiaoui, S., Fagnere, C., Pouget, C., Buxeraud, J., and Chulia, A.-J., New 7,8-benzoflavanones as potent aromatase inhibitors: Synthesis and biological evaluation. Bioorg. Med. Chem., 16, 1474-1480 (2008).   DOI   ScienceOn
18 Yamada, H., Tateishi, M., Harada, K., Ohashi, T., Shimizu, T., Atsumi, T., Komagata, Y., Iijima, H., Komiyama, K., Watanabe, H., Hara, Y., and Ohashi, K., A randomized clinical study of tea catechin inhalation effects on methicillin-resistant Staphylococcus aureus in disabled elderly patients. J. Am. Med. Dir. Assoc., 7, 79-83 (2006).   DOI   ScienceOn
19 Levy, R.M., Saikovsky, R., Shmidt, E., Khokhlov, A., and Burnett, B.P., Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutr. Res., 29, 298-304 (2009).   DOI   ScienceOn
20 Lee, S.J., Baek, H.J., Lee, C.H., and Kim, H.P., Anti-inflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch. Pharm. Res., 17, 31-35 (1994).   DOI
21 Liao, H.-L. and Hu, M.-K., Synthesis and anticancer activities of 5,6,7- trimethylbaicalein derivatives. Chem. Pharm. Bull., 52, 462-465 (2004).
22 Lin, C.-N., Lee, T.-H., Hsu, M.-F., Wang, J.-P., Ko, F.-N., and Teng, C.- M., 2'.5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. J. Pharm. Pharmacol., 49, 530-536 (1997).   DOI   ScienceOn
23 Liu, T., Xu, Z., He, Q., Chen, Y., Yang, B., and Hu, Y., Nitrogencontaining flavonoids as CDK1/cyclin B inhibitors: Design, synthesis, and biological evaluation. Bioorg. Med. Chem. Lett., 17, 278-281 (2007).   DOI   ScienceOn
24 Hirano, T., Oka, K., Kawashima, E., and Akiba, M., Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci., 45, 1407-1441 (1989).   DOI   ScienceOn
25 Han, C.K., Son, M.J., Chang, H.W., Chi, Y.S., Par, H., and Kim, H.P., Inhibition of prostaglandin production by a structurally-optimized flavonoid derivative, 2',4',7-trimethoxyflavone and cellular action mechanism. Biol. Pharm. Bull., 28, 1366-1370 (2005).   DOI   ScienceOn
26 Havsteen, B., Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32, 1141-1148 (1983).   DOI   ScienceOn
27 Herencia, F., Ferrandiz, M.L., Ubeda, A., Gwillen, I., Dominguez, J.N., Charris, J.E., Lobo, G.M., and Alcaraz, M.J., Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett., 453, 129-134 (1999).   DOI   ScienceOn
28 Losiewicz, M.D., Carlson, B.A., Kaur, G., Sausville, E.A., and Worland, P.J., Potent inhibition of CDC2 kinase activity by the flavonoid L86- 8275. Biochem. Biophys. Res. Comm., 201, 589-595 (1994).   DOI   ScienceOn
29 Ullmann, U., Metzner, J., Frank, T., Cohn, W., and Riegger, C., Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers. Adv. Ther., 22, 65-78 (2005).   DOI   ScienceOn
30 Vasquez-Martinez, Y., Ohri, R.V., Kenyon, V., Holman, T.R., and Sepulveda-Boza, S., Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15hLO-1, and prostate epithelial 15hLO-2. Bioorg. Med. Chem., 15, 7408-7425 (2007).   DOI   ScienceOn
31 McAnulty, S.R., McAnulty, L.S., Nieman, D.C., Quindry, J.C., Hosick, P.A., Hudson, M.H., Still, L., Henson, D.A., Milne, G.L., Morrow, J.D., Dumke, C.L., Utter, A.C., Triplett, N.T., and Dibarnardi, A., Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation. Appl. Physiol. Nutr. Metab., 33, 254-262 (2008).   DOI   ScienceOn
32 Middleton, E., Kandaswami, C., and Theoharides, T.C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52, 673-751 (2000).
33 Moon, Y.J., Wang, L., DiCenzo, R., and Morris, M.E., Quercetin pharmacokinetics in humans. Biopharm. Drug. Dispos., 29, 205-217 (2008).   DOI   ScienceOn
34 Nagai, T., Miyaichi, Y., Tomimori, T., and Yamada, H., Inhibition of mouse liver sialidase by plant flavonoids. Biochem. Biophys. Res. Comm., 163, 25-31 (1989).   DOI   ScienceOn
35 Park, H., Dao, T.T., and Kim, H.P., Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives. Eur. J. Med. Chem., 40, 943-948 (2005).   DOI   ScienceOn
36 Quintin, J., Buisson, D., Thoret, S., Cresteil, T., and Lewin, G., Semisynthesis and antiproliferative evaluation of a series of 3'- aminoflavones. Bioorg. Med. Chem. Lett., 19, 3502-3506 (2009).   DOI   ScienceOn
37 Lebeau, J., Furman, C., Bernier, J.-U., Duriez, P., Teissier, E., and Cotelle, N., Antioxidant properties of di-tert-butylhydroxylated flavonoids. Free Rad. Biol. Med., 29, 900-912 (2000).   DOI   ScienceOn
38 Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H., Heliovaara, M., Reunanen, A., Hakulinen, T., and Aromaa, A., Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr., 76, 560-568 (2002).   DOI
39 Kim, S.J., Park, H., and Kim, H.P., Inhibition of nitric oxide production from lipopolysaccharide-treated RAW264.7 cells by synthetic flavones: Structure-activity relationship and action mechanism. Arch. Pharm. Res., 27, 937-943 (2004b).   과학기술학회마을   DOI   ScienceOn
40 Kim, Y.H., Kim, J., Park, H., and Kim, H.P., Anti-inflammatory activity of the synthetic chalcone derivatives: Inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharidetreated RAW 264.7 cells. Biol. Pharm. Bull., 30, 1450-1455 (2007).   DOI   ScienceOn
41 Kometani, T., Fukuda, T., Kakuma, T., Kawaguchi, K., Tamura, W., Kumazawa, Y., and Nagata, K., Effects of $\alpha$-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans. Immunopharmacol. Immunotoxicol., 30, 117-134 (2008).   DOI   ScienceOn
42 Ferry, D.R., Smith, A., Malkhandi, J., Fyfe, D.W., de Takats, P.G., Anderson, D., Baker, J., and Kerr, D.J., Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research, 2, 659-668 (1996).
43 Horie, T., Tsukayama, M., Kourai, H., Yokoyama, C., Furukawa, M., Yoshimoto, T., Yamamoto, S., Waranabe-Kohno, S., and Ohata, K., Synthesis of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase. J. Med. Chem., 29, 2256-2262 (1986).   DOI
44 Egert, S., Bosy-Westphal, A., Seiberi, J., Kurbitz, C., Settler, U., Plachta- Danielzik, S., Wagner, A.E., Frank, J., Schrezenmeir, J., Rimbach, G., Wolffran, S., and Muller, M.J., Quercetin reduces systolic blood pressure and plasma oxidized low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr., 102, 1065-1074 (2009).   DOI   ScienceOn
45 Ertan, R., Goker, H., Ertan, M., Beretz, A., Cazenave, J.P., Haag, M., and Anton, R., Synthesis of some flavone derivatives: potent inhibitors of human platelet aggregation. Chimie, 26, 735-738 (1991).
46 Filipe, P., Silva, A.M.S., Seixas, R.S.G.R., Pinto, D.C.G.A., Santos, A., Patterson, L.K., Silva, J.N., Cavaleir, J.A.S., Freitas, J.P., Maziere, J.- C., Santus, R., and Morliere, P., The alkyl chain length of 3-alkyl- 3',4',5,7-tetrahydroxyflavones modulates effective inhibition of oxidative damage in biological systems: Illustration with LDL, red blood cells and human keratinocytes. Biochem. Pharmacol., 77, 957- 964 (2009).   DOI   ScienceOn
47 Gabor, M., Anti-inflammatory and anti-allergic properties of flavonoids, In Cody et al. (eds.), Plant flavonoids in biology and medicine: Biochemical, pharmacological, and structure-activity relationships, Alan R. Liss, New York, 1986, pp. 471-480.
48 Joo, A.H., Kim, J.K., Kang, S.-H., Noh, M.-S., Ha, J.-Y., Choi, J.K., Lim, K.M., Lee, C.H., and Chung, S., 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 13, 413-417 (2003).   DOI   ScienceOn
49 Huang, W.-H., Lee, A.-R., Chien, P.-Y., and Chou, T.-Z., Synthesis of baicalein derivatives as potential antiaggregatory and antiinflammatory agents. J. Pharm. Pharmacol., 57, 219-225 (2005).   DOI   ScienceOn
50 Jang, J., Kim, H.P., and Park, H., Structure and anti-inflammatory activity relationships of wogonin derivatives. Arch. Pharm. Res., 28, 877-884 (2005).   과학기술학회마을   DOI   ScienceOn
51 Kim, H.P., Son, K.H., Chang, H.W., and Kang, S.S., Anti-inflammatory flavonoids and cellular action mechanisms. J Pharmacol. Sci., 96, 229-245 (2004a).   DOI   ScienceOn
52 Cunningham, B.D.M., Threadgill, M.D., Grounwater, P.W., Dale, I.L., and Hickman, J.A., Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anti- Cancer Drug Design, 7, 365-384 (1992).
53 Gao, H. and Kawabata, J.,$alpha$-Glucosidase inhibition of 6-hydroxyflavones. Part 3: Synthesis and evaluation of 2,3,4-trihydroxybenzoylcontaining flavonoid analogs and 6-aminoflavones as $alpha$-glucosidase inhibitors. Bioorg. Med. Chem., 13, 1661-1671 (2005).   DOI   ScienceOn
54 Gugler, R., Leschik, M., and Dengler, H.J., Disposition of quercetin in man after single oral and intraveneous doses. Eur. J. Clin. Pharmacol., 9, 229-234 (1975).   DOI   ScienceOn
55 Conti, C., Desideri, N., Orsi, N., Sestili, I., and Stein, M.L., Synthesis and antirhinovirus activity of cyano and amidino substituted flavanoids. Eur. J. Chem., 25, 725-730 (1990).   DOI
56 Dao, T.T., Chi, Y.S., Kim, J., Kim, H.P., Kim, S.H., and Park, H., Synthesis and PGE2 inhibitory activity of 5,7-dihydroxyflavones and their O-methylated flavone analogs. Arch. Pharm. Res., 26, 345-350 (2003a).   과학기술학회마을   DOI   ScienceOn